Category: approved

A. flavus, A. fumigatus, A. niger, A. terreus, accredit, accreditation, analysis, analytics, Anthony Repay, AOAC, approval, approved, aspergillus, business, cannabis, Cannabis Analytical Science Program, CASP, certified, compliance, consumer, government, growing, industry, international, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, method, methods, official, performance, positive, product, Quality, RC - Cannabis Analysis, recreational, regulation, regulations, regulatory, safety, standard, state, test, tested, Testing, thc, unconfirmed

AOAC Accreditation: Why Third-Party Approval Matters More Than Ever

AOAC Accreditation: Why Third-Party Approval Matters More Than Ever

When people have to make important decisions, we often consult a third party to increase our knowledge and confidence in a product. […]

adult, analysis, analytics, applicant, application, apply, approval, approve, approved, Ascend, Ayr, business, Business Analysis, cannabis, Cannabis Regulatory Commission, compliance, conditional, CQC, CQCExpo, CRC, curaleaf, dispensaries, Dispensaries & Retail, dispensary, executive director, government, growing, industry, Jeff Brown, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, licensing, location, marijuana, market, medical, medicine, meeting, municipality, new jersey, NJ, NJCRC, notes, product, public, Quality, rec, recreational, regulation, regulations, regulators, regulatory, retail, safety, sales, state, TerrAscend, test, testified, testify, thc, use, wellness

One Month In: New Jersey Market Starts Growing

One Month In: New Jersey Market Starts Growing

Just over a month ago, a handful of dispensaries in New Jersey began selling cannabis to adults over the age of 21. […]

action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]